|


SemaCo, Inc.
SemaCo has been founded from technology emanating from Boston University's Dermatology department. The company will develop therapeutics aimed at a wide variety of diseases including Cancer and Alzheimer's. Additionally, dermatology technology will be developed for use in cosmetics applications. SemaCo has raised initial seed capital and is pursuing pharmaceutical partnerships.
|